Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ångström is a Swedish biotechnology company that specializes in the development of advanced nanostructured surfaces for medical applications. The company leverages its expertise in nanotechnology to create bioactive coatings that enhance the performance of medical implants and diagnostic tools. Their primary focus is on improving osseointegration for orthopedic and dental implants while simultaneously providing antimicrobial properties to prevent infections. By manipulating materials at the atomic level, Ångström aims to bridge the gap between synthetic materials and biological systems. The company's technology is rooted in research from the Ångström Laboratory at Uppsala University.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AB Ångström.